US Patent Issued to University of South Carolina on Nov. 3 for "Micro-RNA-155 enhances the efficacy of dendritic cell vaccine for cancer" (South Carolina Inventor)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,037, issued on Nov. 3, was assigned to University of South Carolina (Columbia, S.C.).

"Micro-RNA-155 enhances the efficacy of dendritic cell vaccine for cancer" was invented by Daping Fan (Columbia, S.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Engineered dendritic cell vaccines, and methods of forming and applying same, that may be used as effective immunotherapies for cancers."

The patent was filed on July 26, 2021, under Application No. 17/384,993.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&...